by TendoNova
The Ocelot system™
Redefining fragmentation and debridement treatment for ASC and In-office. The precision of surgery, but at a fraction of the cost.
*Now 510(k) CLEARED. Refer to user manual for indications and safety.
Building with passion and ingenuity.
NFL 1st & Future
NFLPA
Tech OUT
MassMEDIC
STARTUP Pitch Night
YEi Start in France
TendoNova Corporation’s mission is to enhance clinical outcomes for patients with chronic tendon pain by delivering cutting-edge micro-invasive technology that is customizable to individual patient needs without overwhelming expense.
The Problem
Tendinopathy is an injury that has failed to heal and is one of the most common causes of pain in the world.
30M
30 million Americans have chronic tendon pain (lasting over 3 months).
5
Five commonly affected tendon areas include: jumper’s knee, tennis elbow, golf elbow, plantar fasciitis, Achilles tendinopathy, and other tendons.
9M
9 million Americans fail to respond to conservative treatment.
$1.4B
Approximately $1.4 billion of the market is currently unmet.
Current Approach
The existing methods for treating chronic tendon pain are expensive, complex and have variable outcomes. Our approach is to provide a simple, effective tool that can be easily adopted in a physician’s office.
The Ocelot System™ offers an alternative to:
Conservative Treatment
Percutaneous Tenotomy
Open Surgery
"After 15 years of treating elite and recreational athletes for tendinopathy, I have been frustrated by the tools we have had to help heal these injuries. The TendoNova device could be a game changer in getting our athletes back to the healthiest level possible."
Kenneth Mautner M.D.
Medical Advisor
Introducing
THE OCELOT SYSTEM™
A microinvasive technology designed to perform fragmentation or debridement of soft tissue, which are commonly used as part of percutaneous tenotomy procedures under ultrasound-guidance.
The Ocelot System™ was conceived in response to a request by Atlanta Hawks head team physician Dr. Kenneth Mautner for an improved tool. The Ocelot System's form factor and price point make it an exciting alternative to existing tools.
Now 510(k) CLEARED. Refer to user manual for indications and safety.
How it works
Bringing surgical-level care to the office.
01
Stimulation
Ocelot System mechanically fragments soft tissue. In certain procedures (most often percutaneous tenotomy), soft tissue with excessive scar tissue is fragmented for a new healing cycle.
02
Activation
Pro inflammatory markers (e.g. macrophages, neutrophils, and cytokines) activate to start upregulation.
03
Upregulation
Proteins and growth factors (e.g. IG-F1, TGFβ, PDGF, bFGF, Interleukin) start expressing in the area.
04
Healing
Soft tissue repairs and remodels itself to a healthy new state.
Why Us
Next-generation technology that meets the needs of physicians, payers, and patients.
Decrease cost of care
Less expensive and invasive than alternative procedures that need to be done in the OR or Ambulatory Surgical Suite
Improve clinical outcomes
We intend to show post market clinical studies that use standardized objective measurements to improve both novice and expert clinician’s outcomes
Improve patient experience
- Reduce time and cost with both office visit or ASC treatment option
- Increase comfort and greater precision than existing tools
- Require less movement inside the body
Improve physician experience
- Wireless, with little set up time
- Objective measurements on which to base and defend clinical decisions
- Economical without sacrificing results
TendoNova
The Team
We are a powerful blend of medical device and sports medicine specialists dedicated to helping people live healthier lives with less pain and fewer injuries.
Over 30 years of experience in Medical Device, recent successful exit and prior IPO. Inventor on over 25 patents.
Sales executive with a proven history of success and achievement in medical devices including 15 years of experience at Arthrex and Stryker prior.
Medical Device Executive with 30+ years of experience in commercialization, R&D, manufacturing, supply chain, and regulatory. Veteran of start-up & growth stage medical device companies.
Medical Device Executive with 30+ years of experience in commercialization, R&D, manufacturing, supply chain, and regulatory. Veteran of start-up & growth stage medical device companies.
Dr. Mautner is the Assistant Professor in the Department of Physical Medicine and Rehabilitation and the Department of Orthopaedic Surgery at Emory University. He is also the Director of Primary Care Sports Medicine and Fellowship Director at Primary Care Sports Medicine Fellowship.
Dr. Mautner is a co-editor of the Atlas of Interventional Musculoskeletal Ultrasound and Musculoskeletal Physical Examination: An Evidence Based Physical Approach. Dr. Mautner is considered a leader in the field of orthobiologics treatment for chronic soft tissue and joint disorders including Platelet Rich Plasma (PRP) and stem cell injections.
Dr. Mautner is a co-editor of the Atlas of Interventional Musculoskeletal Ultrasound and Musculoskeletal Physical Examination: An Evidence Based Physical Approach. Dr. Mautner is considered a leader in the field of orthobiologics treatment for chronic soft tissue and joint disorders including Platelet Rich Plasma (PRP) and stem cell injections.
Dr. Malanga is the Founder and Partner of New Jersey Sports Medicine, LLC and New Jersey Regenerative Institute in Cedar Knolls, New Jersey. He is board certified in physical medicine and rehabilitation, sports medicine and pain medication.
Dr. Malanga is trained in nonoperative treatment of a variety of orthopedic disorders including neck and back pain, as well as shoulder, knee, and other sports medicine and musculoskeletal problems. Dr. Malanga’s expertise includes EMG testing, spinal and joint injections, musculoskeletal ultrasound and PRP, bone marrow and adipose-derived stem cell treatments.
Dr. Malanga is trained in nonoperative treatment of a variety of orthopedic disorders including neck and back pain, as well as shoulder, knee, and other sports medicine and musculoskeletal problems. Dr. Malanga’s expertise includes EMG testing, spinal and joint injections, musculoskeletal ultrasound and PRP, bone marrow and adipose-derived stem cell treatments.
Dr. Jennings is the Director of Silicon Valley Foot & Ankle Reconstructive Fellowship at Palo Alto Medical Foundation. She is a board-certified foot and ankle surgeon with a focus on trauma, reconstruction, and sports medicine at Palo Alto Medical Foundation.
Dr. Jennings’s expertise includes Achilles tendon, biomechanics, bunions, diabetic limb salvage, endoscopic plantar fascia surgery, foot surgery, heel surgery, and sports medicine.
Dr. Jennings’s expertise includes Achilles tendon, biomechanics, bunions, diabetic limb salvage, endoscopic plantar fascia surgery, foot surgery, heel surgery, and sports medicine.
Dr. Desai is the founder of RestorePDX, specializing in musculoskeletal radiology and interventional joint and spine medicine. He currently sits on the Board of Directors for the Interventional Orthopedics Foundation.
Dr. Desai has expanded his musculoskeletal imaging background (MSK ultrasound, diagnostic MRI, CT, X-ray, interventional fluoroscopy) in combination with PRP, stem cells, and regenerative medicine.
Dr. Desai has expanded his musculoskeletal imaging background (MSK ultrasound, diagnostic MRI, CT, X-ray, interventional fluoroscopy) in combination with PRP, stem cells, and regenerative medicine.
Contact us
For early access
Please send early access requests using the contact form.
For investors
We are accepting investor requests at the moment. Please email mark.samuels@tendonova.com regarding product interest and investor inquiries.